“While claims 90101 and 90102 appear contradictory—global hypomethylation boosting resistance vs. DRM2-mediated hypermethylation also boosting resistance—they likely reflect two layers of epigenetic control: a broad demethylation–dependent priming of general defense genes and a targeted DRM2-driven methylation at key jasmonic acid pathway loci. Integrating these yields a unified model in which distinct methylation dynamics act at different genomic regions or stages of infection to enhance resistance.”